SA

Surabhi Agarwal

Active Director Additional Director DIN 11426417
DIN 11426417 First appointment Dec 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Surabhi Agarwal

Data last updated:

Surabhi Agarwal is an Additional Director at Jpee Drugs Private Limited (since 2025). The company operates in Pharma.

DIN 11426417
Primary Designation Additional Director
Industry Pharma
First Appointment 13 Dec 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jpee Drugs Private Limited U24230UR2022PTC014049
Additional Director13 Dec 20252022Active

Board colleagues of Surabhi Agarwal

Directorship timeline

Open interactive timeline →
Jpee Drugs Private Limited
Premium access

Shareholding and investment profile for Surabhi Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Surabhi Agarwal

Surabhi Agarwal currently holds 1 directorship: Jpee Drugs Private Limited (Additional Director, since 13 Dec 2025).

Surabhi Agarwal was first appointed on 13 Dec 2025 as Additional Director at Jpee Drugs Private Limited.

The current boards of Surabhi Agarwal's companies include Sunita Agarwal (Jpee Drugs Private Limited), Vikas Agarwal (Jpee Drugs Private Limited), Vinod Kumar Agarwal (Jpee Drugs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available